{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T23:09:16Z","timestamp":1772060956747,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":2102,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.3945\/jn.116.242750","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T01:00:26Z","timestamp":1490835626000},"page":"754-762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women"],"prefix":"10.1016","volume":"147","author":[{"given":"Hanny","family":"Wassef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Bissonnette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Davignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Faraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3945\/jn.116.242750_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S0828-282X(09)70715-9","article-title":"2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult\u20142009 recommendations","volume":"25","author":"Genest","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.3945\/jn.116.242750_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.3945\/jn.116.242750_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.3945\/jn.116.242750_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6823-12-2","article-title":"The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis","volume":"12","author":"Murad","year":"2012","journal-title":"BMC Endocr Disord"},{"key":"10.3945\/jn.116.242750_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"10.3945\/jn.116.242750_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"10.3945\/jn.116.242750_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2362.1998.00317.x","article-title":"Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall\u2014evidence that plaque cholesterol may be derived from post-prandial lipoproteins","volume":"28","author":"Proctor","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.3945\/jn.116.242750_bib8","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M300299-JLR200","article-title":"ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes","volume":"45","author":"Faraj","year":"2004","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib9","doi-asserted-by":"crossref","DOI":"10.1139\/o03-078","article-title":"Diabetes, lipids, and adipocyte secretagogues","volume":"82","author":"Faraj","year":"2004","journal-title":"Biochem Cell Biol"},{"key":"10.3945\/jn.116.242750_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.8.1.1","article-title":"Apolipoprotein E polymorphism and atherosclerosis","volume":"8","author":"Davignon","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.3945\/jn.116.242750_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MOL.0000000000000146","article-title":"The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia","volume":"26","author":"Sacks","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.3945\/jn.116.242750_bib13","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M113.495366","article-title":"Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets","volume":"288","author":"Larsson","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3945\/jn.116.242750_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00041433-200106000-00009","article-title":"Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism","volume":"12","author":"Shachter","year":"2001","journal-title":"Curr Opin Lipidol"},{"key":"10.3945\/jn.116.242750_bib15","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M007210200","article-title":"Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity","volume":"275","author":"Gautier","year":"2000","journal-title":"J Biol Chem"},{"key":"10.3945\/jn.116.242750_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2008.10.147","article-title":"Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo","volume":"377","author":"de Haan","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3945\/jn.116.242750_bib17","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M200210-JLR200","article-title":"Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase","volume":"43","author":"Conde-Knape","year":"2002","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.112.300306","article-title":"White adipose tissue apolipoprotein C-I secretion in relation to delayed plasma clearance of dietary fat in humans","volume":"32","author":"Wassef","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3945\/jn.116.242750_bib19","doi-asserted-by":"crossref","first-page":"271062","DOI":"10.1155\/2011\/271062","article-title":"The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid athe rosclerosis","volume":"2011","author":"Hansen","year":"2011","journal-title":"J Lipids"},{"key":"10.3945\/jn.116.242750_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00365518909089080","article-title":"Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia","volume":"49","author":"Annuzzi","year":"1989","journal-title":"Scand J Clin Lab Invest"},{"key":"10.3945\/jn.116.242750_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)33305-8","article-title":"An efficient chromatographic system for lipoprotein fractionation using whole plasma","volume":"39","author":"Innis-Whitehouse","year":"1998","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)38097-4","article-title":"Factors affecting the integrity of high density lipoproteins in the ultracentrifuge","volume":"23","author":"Kunitake","year":"1982","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib23","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.P023176","article-title":"Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue","volume":"54","author":"Bissonnette","year":"2013","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib24","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1038\/nutd.2015.30","article-title":"Plasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humans","volume":"5","author":"Bissonnette","year":"2015","journal-title":"Nutr Diabetes"},{"key":"10.3945\/jn.116.242750_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2015.06.012","article-title":"The apoB\/PCSK9 ratio: a new index for metabolic risk in humans","volume":"9","author":"Wassef","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.3945\/jn.116.242750_bib26","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.P064170","article-title":"White adipose tissue apoC-I secretion; role in delayed chylomicron clearance in vivo and ex vivo in white adipose tissue in obese subjects","volume":"57","author":"Cyr","year":"2016","journal-title":"J Lip Res"},{"key":"10.3945\/jn.116.242750_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/42.5.732","article-title":"Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations","volume":"42","author":"Schectman","year":"1996","journal-title":"Clin Chem"},{"key":"10.3945\/jn.116.242750_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2007.02.004","article-title":"Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women","volume":"33","author":"Bastard","year":"2007","journal-title":"Diabetes Metab"},{"key":"10.3945\/jn.116.242750_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)31166-4","article-title":"Enhanced dietary fat clearance in postobese women","volume":"42","author":"Faraj","year":"2001","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib30","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.D300041-JLR200","article-title":"Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE","volume":"45","author":"Cohn","year":"2004","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)38611-9","article-title":"Enzyme-linked immunosorbent assay for human plasma apolipoprotein B","volume":"28","author":"Ordovas","year":"1987","journal-title":"J Lip Res"},{"key":"10.3945\/jn.116.242750_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.16.1.149","article-title":"Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects","volume":"16","author":"Cohn","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3945\/jn.116.242750_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)37424-1","article-title":"Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions","volume":"38","author":"Fredenrich","year":"1997","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib34","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M200055-JLR200","article-title":"Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects","volume":"43","author":"Cohn","year":"2002","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2005.01.005","article-title":"Apolipoproteins C-II and C-III inhibit selective uptake of low- and high-density lipoprotein cholesteryl esters in HepG2 cells","volume":"37","author":"Huard","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.3945\/jn.116.242750_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2275(20)38485-6","article-title":"Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal","volume":"29","author":"Cohn","year":"1988","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib37","doi-asserted-by":"crossref","first-page":"E150","DOI":"10.1152\/ajpendo.00398.2003","article-title":"Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP","volume":"287","author":"Faraj","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.3945\/jn.116.242750_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc"},{"key":"10.3945\/jn.116.242750_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0021-9150(03)00139-4","article-title":"Plasma concentration and lipoprotein distribution of ApoC-I is dependent on ApoE genotype rather than the Hpa I ApoC-I promoter polymorphism","volume":"169","author":"Cohn","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.3945\/jn.116.242750_bib40","doi-asserted-by":"crossref","first-page":"e1002480","DOI":"10.1371\/journal.pgen.1002480","article-title":"A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation","volume":"8","author":"Naitza","year":"2012","journal-title":"PLoS Genet"},{"key":"10.3945\/jn.116.242750_bib41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1194\/jlr.M400301-JLR200","article-title":"Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL","volume":"46","author":"Berb\u00e9e","year":"2005","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib42","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M500434-JLR200","article-title":"Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL","volume":"47","author":"Westerterp","year":"2006","journal-title":"J Lipid Res"},{"key":"10.3945\/jn.116.242750_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/sj.ki.5002449","article-title":"Hemodialysis reduces plasma apolipoprotein C-I concentration making VLDL a better substrate for lipoprotein lipase","volume":"72","author":"Dautin","year":"2007","journal-title":"Kidney Int"},{"key":"10.3945\/jn.116.242750_bib44","doi-asserted-by":"crossref","DOI":"10.1042\/bj3380281","article-title":"Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor","volume":"338","author":"Jong","year":"1999","journal-title":"Biochem J"},{"key":"10.3945\/jn.116.242750_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)55263-7","article-title":"Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway","volume":"266","author":"Sehayek","year":"1991","journal-title":"J Biol Chem"},{"key":"10.3945\/jn.116.242750_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)45726-2","article-title":"Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein","volume":"265","author":"Weisgraber","year":"1990","journal-title":"J Biol Chem"},{"key":"10.3945\/jn.116.242750_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-006-0056-2","article-title":"Dual roles of apolipoprotein CI in the formation of atherogenic remnants","volume":"8","author":"Bj\u00f6rkegren","year":"2006","journal-title":"Curr Atheroscler Rep"},{"key":"10.3945\/jn.116.242750_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2012.01.026","article-title":"Proteomic analysis of the very low density lipoprotein (VLDL) transport vesicles","volume":"75","author":"Rahim","year":"2012","journal-title":"J Proteomics"},{"key":"10.3945\/jn.116.242750_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.109.197830","article-title":"Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins","volume":"30","author":"Mendivil","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3945\/jn.116.242750_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/JCI116066","article-title":"Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice: diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles","volume":"90","author":"Aalto-Set\u00e4l\u00e4","year":"1992","journal-title":"J Clin Invest"}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622107297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622107297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3945\/jn.116.242750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T09:53:47Z","timestamp":1719136427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316622107297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0022316622107297"],"URL":"https:\/\/doi.org\/10.3945\/jn.116.242750","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/jn.116.242750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}